Skip to content

The establishment of a PRO-based PARPi maintenance treatment management system for patients with epithelial ovarian cancer

The establishment of a PRO-based PARPi maintenance treatment management system for patients with epithelial ovarian cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085888
Enrollment
Unknown
Registered
2024-06-20
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Intervention group:Using the PARPI maintenance therapy management platform for epithelial ovarian cancer, providing specialized symptom management and intervention for patients with maintenance treat

Sponsors

The Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The patient has good compliance and knowingly agreed to participate in the clinical study; (2) Age: 16-80 years old; (3) Stage II-IV ovarian epithelial cancer after standard surgery and chemotherapy; (4)Complete or partial remission is achieved after first-line treatment, and PARPi maintenance therapy is proposed; (5) Blood routine does not exceed I degree of myelmarrow suppression.

Exclusion criteria

Exclusion criteria: (1) Patients with severe primary diseases such as heart, liver and kidney; (2) People with serious mental illness or mental illness; (3) malignant tumors originating in other sites; (4) More than 4 symptom data are missing.

Design outcomes

Primary

MeasureTime frame
Adverse effects of PARPI ;

Secondary

MeasureTime frame
Progression-free survival;Biochemical recurrence;Anxiety assessment;Sleep quality assessment;

Countries

China

Contacts

Public ContactYuhua Zeng

The Affiliated Hospital of North Sichuan Medical College

2742796290@qq.com+86 159 8377 5560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026